ForSight Robotics raises $55 million for robotic cataract surgery platform
Click Here to Manage Email Alerts
ForSight Robotics raised $55 million in a Series A round to advance its fully robotic cataract surgery platform, according to a press release.
The funding round was led by the Adani Group along with existing investors Eclipse Ventures and Mithril Capital and new investors Provenio Capital, Precision Capital, Reiya Ventures and the Ljungstrom family office, among others.
The platform, called Oryom, aims to automate ophthalmic surgery and be more accurate than manual surgery, the release said.
In 2021, ForSight raised $10 million in a mega-seed round.
“We are pleased to be able to advance our technology with this investment to bring robotics into the world of ophthalmic surgery to help millions of patients who have to wait unnecessarily for procedures while their eyesight deteriorates,” Daniel Glozman, PhD, CEO and co-founder of ForSight, said in the release. “Our goal is to democratize this highly sophisticated procedure, enabling patients around the world to easily access the treatment that can restore their vision.”